All products / DC21257
LY2780301
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $700 USDRequest a quote / confirm availability → |
| 250 mg | $1,200 USDRequest a quote / confirm availability → |
| 1 g | $2,500 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
A potent, highly selective, ATP-competitive dual inhibitor of p70S6K and Akt under development for the treatment of solid tumours and non-Hodgkin's lymphoma; drastically decreases proliferation of hMECs with ErbB2-induced p70S6K activation via Cyclin B1 inhibition and cell cycle blockade at G0-G1 phase; exhibited antiproliferative activity in a broad range of cell lines using monolayer and colony formation assays, reduces proliferation of hMECs in vitro and ADH/MIN lesions in vivo.Breast CancerPhase 2 Clinical
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC21257 |
|---|---|
| Product name | LY2780301 |
| CAS | 1226801-23-5 |
| Molecular formula | C25H27F4N7O |
| Molecular weight | 517.521798372269 |
| Purity | >98% |
| SMILES | CN(C)CCn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3c2CC(=O)N3)CC1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — LY2780301 (DC21257)